Adds Merger & Acquisition and Legal Experience
HICKSVILLE, NY -- July 29, 2019 -- InvestorsHub NewsWire
-- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the
“Company”), a developer, manufacturer, and seller of a
variety of Cannabidiol (Hemp) based products such as oils, creams,
moisturizers, chews, isolate, gel caps, and concentrate, announced
today the appointment of John Bach to its Corporate Advisory
Board.
Canbiola Chief Executive Officer Marco Alfonsi commented,
“We are pleased to welcome John to our team, as the newest member
of our Corporate Advisory Board. John brings over 40 years of
relationships and experience, especially in mergers and
acquisitions and the legal and structural sides of transactions. We
look forward to John providing input and guidance as we seek to
advance our growth at Canbiola.”
John Bach stated, “I am excited to join Marco and the Canbiola
team. They have assembled a remarkable group of people to bring
their CBD products and solutions to the medical and consumer
markets. I look forward to assisting in any way I can to help the
Company achieve its goals of being a significant participant in the
emerging CBD market.”
Since 1998, Mr. Bach has been Chief Business Development Officer
and General Counsel to The Whitmore Group, Ltd., a full-service
insurance brokerage and financial services. His chief
responsibilities have included identifying potential Merger and
Acquisition candidates, and analyzing, conducting due diligence and
structuring acquisition of candidates for Whitmore, as well as
advising on legal issues related to corporate governance,
litigation and business transactions and regulatory issues related
to insurance brokerage industry. During his tenure Whitmore
had grown four-fold to become one of the top 5 independent brokers
in the New York metropolitan area.
While at Whitmore, Mr. Bach founded in 2008, Private Client
Realty Group, a Garden City, New York boutique real estate
brokerage, investment and acquisition firm whose mission is to
identify real estate investment and development opportunities and
provide to a limited number of discerning clientele unlimited real
estate services with confidential and personal attention.
Prior to joining Whitmore, Mr. Bach was tasked with turning
around TSI Environmental, Inc. d/b/a Three Seasons Environmental.
He joined TSI in 1996 initially as COO and General Counsel.
Three months hereafter, Mr. Bach was elected Chairman of the Board
and appointed President/CEO. In his positions, Mr. Bach
oversaw all aspects of the management, marketing, and development
of the company. During his tenure, Mr. Bach reorganized and
turned the company around, permitting the firm to emerge out of
Chapter 11 bankruptcy protection. Within the following year,
he increased sales over 400%, which afforded shareholders the
opportunity to sell the entity in 1998 for $12.5 million.
Before to his affiliation with TSI Environmental, Inc., Mr. Bach
was principal, officer, and director of several privately held
companies, including President of Atlantic Coast Construction Co.
of New York, and Vice-President and General Counsel to Hugh P.
Gaffney Co., Inc., a real estate development and brokerage firm. In
these various positions, Mr. Bach's responsibilities included
negotiations, acquisitions, and development of single-family
residential/commercial properties; complete oversight of the
acquisition and development process, including negotiation of
contracts, implementation of development plans, and review of all
zoning and governmental regulations; and design, oversight,
supervision, and construction of projects.
Mr. Bach began his professional career as Legislative Counsel to
Hon. John R. Dunne, New York State Senate. His first task was his
appointment as Minority Counsel to the New York State Temporary
Commission on Management and Productivity in the Public Sector.
Subsequently, Mr. Bach joined the firm of Sprague, Dwyer, Aspland,
and Tobin, P.C. in Garden City, New York and specialized in Banking
and Real Estate which involved him in the negotiation and drafting
of real estate contracts and commercial transactions; counseling of
financial institutions (commercial bank and savings and loan
association) regarding regulations and transactions; and real
estate zoning. Mr. Bach opened his own private practice in 1978 and
has practiced law for over forty-three years, having specialized in
real estate, real estate development, zoning, and commercial
transactions.
Mr. Bach received his Bachelor of Arts Degree in English
Literature in 1972 from St. John's University, St. John's College,
Jamaica, New York as well as his Doctor of Jurisprudence in 1975
from St. John's University, School of Law. He attended the Master
of Law Program at New York University, School of Law, New York, New
York from 1975 to 1976, focusing on Municipal Law and Municipal
Finance. Advisor – Advisor Trustee to American Academy of
Hospitality Sciences, Counsel to Frederick Douglas Republicans.
About Canbiola, Inc.
Canbiola, Inc. (OTCQB: CANB) is a developer, manufacturer,
and seller of a variety of Cannabidiol (Hemp) based products such
as oils, creams, moisturizers, chews, isolate gel caps and
concentrates. Canbiola has developed its own line of proprietary
products as well as seeking synergistic value through acquisitions
in the CBD and the medical cannabis industry. Cannabis is currently
federally illegal and has legalized for medical purposes in some
form in a limited number of states, but pure CBD products are legal
in all 50 states. Hemp CBD is the non-psychoactive component (No
THC) used for treatment of pain, inflammation, and wellness
programs. For more information about Canbiola, Inc., please
visit https://canbiola.com.
Additionally, Canbiola’s wholly-owned subsidiary Pure Health
Products, based in Lacey, WA, is its prime development laboratory
and production facility. Canbiola’s Duramed division has
recently rolled out a durable medical device via its Doctor network
to treat patients with injuries via application of an in-home
ultrasound sustained acoustic device (SAM) for pain and
inflammation reduction.
Forward-Looking Statements
Forward-looking statements and risks and uncertainties discussed
in this letter contain forward-looking statements. The words
"anticipate," "believe," "estimate," "may," "intend," "expect," and
similar expressions identify such forward-looking statements.
Expected, actual results, performance, or achievements could differ
materially from those contemplated, expressed, or implied by the
forward-looking statements contained herein. Forward-looking
statements are subject to a number of risks and uncertainties,
including but not limited to, risks and uncertainties associated
with, among other things, the impact of economic, competitive, and
other factors affecting our operations, markets, products, and
performance. The matters discussed herein should not be construed
in any way, shape or manner of our future financial condition or
stock price.
Follow Canbiola on:
Twitter @CanbiolaHealth
Instagram @canbiola.inc or @canbiola_cbd or
@canbiola_medical_cbd
Follow us
on Twitter and Facebook
Investors and Media:
IR@canbiola.com
(516) 595-9544
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Mar 2024 to Apr 2024
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Apr 2023 to Apr 2024